Stock OGEN ORAGENICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Oragenics, Inc.

Equities

OGEN

US6840235005

Delayed Nyse
Other stock markets
 02:42:13 2024-04-25 pm EDT 		5-day change 1st Jan Change
1.12 USD +2.75% Intraday chart for Oragenics, Inc. -0.88% -80.09%
Apr. 12 North American Morning Briefing : Big Banks Kick -2- DJ
Mar. 29 Oragenics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Oragenics, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards
BU
North American Morning Briefing : Big Banks Kick -2-
DJ
Oragenics, Inc. Files 10K and Provides Company Update
BU
Oragenics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Oragenics Appoints James Kelly MD, Chief Medical Officer, to Lead Phase II Clinical Trials for Treating Concussion
BU
Oragenics Appoints James Kelly MD as Chief Medical Officer, to Lead Phase II Clinical Trials for Treating Concussion
CI
Oragenics, Inc. Prepares Drug for Phase II Clinical Trials to Treat Concussion
BU
Oragenics, Inc. Prepares Drug for Phase II Clinical Trials to Treat Concussion
CI
Oragenics Announces Closing of Public Offering
AQ
Oragenics Announces Closing of Public Offering
BU
Top Midday Decliners
MT
Oragenics Announces Pricing of Public Offering
BU
Oragenics Announces Proposed Public Offering
BU
Oragenics CEO Kimberly Murphy Steps Down, Board Chair to Serve as Interim Executive Chair
MT
Oragenics, Inc. Announces Leadership Transition
BU
Oragenics, Inc. Announces Leadership Transition
CI
Oragenics, Inc. Announces CEO Changes
CI
Oragenics, Inc. Announces Expiration of Its Investment Banking Engagement Agreement
BU
Oragenics, Inc. Preparing for Phase II Clinical Trials to Treat Concussion
BU
Oragenics, Inc. Prepares for Phase II Clinical Trials to Treat Concussion
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. OGEN Stock
  4. News Oragenics, Inc.